These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 25662589)

  • 1. Tissue-engineered models of human tumors for cancer research.
    Villasante A; Vunjak-Novakovic G
    Expert Opin Drug Discov; 2015 Mar; 10(3):257-68. PubMed ID: 25662589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Cancer Drug Validation: the Contribution of Tissue Engineered Models.
    Carvalho MR; Lima D; Reis RL; Oliveira JM; Correlo VM
    Stem Cell Rev Rep; 2017 Jun; 13(3):347-363. PubMed ID: 28233276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensionally engineered biomimetic tissue models for in vitro drug evaluation: delivery, efficacy and toxicity.
    Peck Y; Wang DA
    Expert Opin Drug Deliv; 2013 Mar; 10(3):369-83. PubMed ID: 23289593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered microenvironments provide new insights into ovarian and prostate cancer progression and drug responses.
    Loessner D; Holzapfel BM; Clements JA
    Adv Drug Deliv Rev; 2014 Dec; 79-80():193-213. PubMed ID: 24969478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The application of engineered liver tissues for novel drug discovery.
    Lin C; Ballinger KR; Khetani SR
    Expert Opin Drug Discov; 2015 May; 10(5):519-40. PubMed ID: 25840592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer drug discovery: recent innovative approaches to tumor modeling.
    Lovitt CJ; Shelper TB; Avery VM
    Expert Opin Drug Discov; 2016 Sep; 11(9):885-94. PubMed ID: 27454169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioengineered tumors.
    Villasante A; Vunjak-Novakovic G
    Bioengineered; 2015; 6(2):73-6. PubMed ID: 25616977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal models of disease: pre-clinical animal models of cancer and their applications and utility in drug discovery.
    Ruggeri BA; Camp F; Miknyoczki S
    Biochem Pharmacol; 2014 Jan; 87(1):150-61. PubMed ID: 23817077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The multicellular tumor spheroid model for high-throughput cancer drug discovery.
    LaBarbera DV; Reid BG; Yoo BH
    Expert Opin Drug Discov; 2012 Sep; 7(9):819-30. PubMed ID: 22788761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue-Engineered Bone Tumor as a Reproducible Human in Vitro Model for Studies of Anticancer Drugs.
    Sakolish C; House JS; Chramiec A; Liu Y; Chen Z; Halligan SP; Vunjak-Novakovic G; Rusyn I
    Toxicol Sci; 2020 Jan; 173(1):65-76. PubMed ID: 31626302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal cancer models for novel drug discovery.
    Golovko D; Kedrin D; Yilmaz ÖH; Roper J
    Expert Opin Drug Discov; 2015; 10(11):1217-29. PubMed ID: 26295972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue-engineered 3D tumor angiogenesis models: potential technologies for anti-cancer drug discovery.
    Chwalek K; Bray LJ; Werner C
    Adv Drug Deliv Rev; 2014 Dec; 79-80():30-9. PubMed ID: 24819220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating drug efficacy and toxicology in three dimensions: using synthetic extracellular matrices in drug discovery.
    Prestwich GD
    Acc Chem Res; 2008 Jan; 41(1):139-48. PubMed ID: 17655274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microfluidic 3D models of cancer.
    Sung KE; Beebe DJ
    Adv Drug Deliv Rev; 2014 Dec; 79-80():68-78. PubMed ID: 25017040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new approach to assess drug sensitivity in cells for novel drug discovery.
    Mazzarella L; Curigliano G
    Expert Opin Drug Discov; 2018 Apr; 13(4):339-346. PubMed ID: 29415581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mathematical modeling for novel cancer drug discovery and development.
    Zhang P; Brusic V
    Expert Opin Drug Discov; 2014 Oct; 9(10):1133-50. PubMed ID: 25062617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organs-on-a-chip: a new tool for drug discovery.
    Polini A; Prodanov L; Bhise NS; Manoharan V; Dokmeci MR; Khademhosseini A
    Expert Opin Drug Discov; 2014 Apr; 9(4):335-52. PubMed ID: 24620821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges with in vitro and in vivo experimental models of urinary bladder cancer for novel drug discovery.
    Oliveira PA; Gil da Costa RM; Vasconcelos-Nóbrega C; Arantes-Rodrigues R; Pinto-Leite R
    Expert Opin Drug Discov; 2016 Jun; 11(6):599-607. PubMed ID: 27077499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted approaches to childhood cancer: progress in drug discovery and development.
    Hirsch S; Marshall LV; Carceller Lechon F; Pearson AD; Moreno L
    Expert Opin Drug Discov; 2015 May; 10(5):483-95. PubMed ID: 25840490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3D in vitro tissue models and their potential for drug screening.
    Kimlin L; Kassis J; Virador V
    Expert Opin Drug Discov; 2013 Dec; 8(12):1455-66. PubMed ID: 24144315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.